Innoviva, Inc.
INVA
$21.46
$0.020.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 61.52% | 48.85% | 136.86% | 93.07% | -2.20% |
| Total Other Revenue | -1.04% | -5.51% | 6.53% | 2.37% | 2.74% |
| Total Revenue | 14.37% | 6.95% | 33.08% | 23.34% | 1.48% |
| Cost of Revenue | 62.30% | -50.45% | -2.25% | -53.97% | -65.10% |
| Gross Profit | 8.84% | 52.56% | 39.48% | 55.84% | 30.05% |
| SG&A Expenses | -9.58% | 19.02% | -8.44% | 17.83% | 54.07% |
| Depreciation & Amortization | 0.54% | 0.02% | 0.00% | 29.89% | 69.25% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.70% | 16.41% | -6.18% | -13.83% | -3.50% |
| Operating Income | 27.64% | -1.43% | 141.00% | 91.72% | 9.21% |
| Income Before Tax | -185.52% | -59.65% | -92.03% | -776.64% | 9.68% |
| Income Tax Expenses | -6.95% | 1,421.82% | 44.29% | -201.52% | 36.92% |
| Earnings from Continuing Operations | -227.52% | -66.96% | -98.52% | -2,809.77% | 4.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -227.52% | -66.96% | -98.52% | -2,809.77% | 4.78% |
| EBIT | 27.64% | -1.43% | 141.00% | 91.72% | 9.21% |
| EBITDA | 23.09% | -1.25% | 103.33% | 82.52% | 16.07% |
| EPS Basic | -228.48% | -66.38% | -98.46% | -2,930.10% | 12.42% |
| Normalized Basic EPS | 36.20% | 7.19% | 162.64% | 108.10% | 16.97% |
| EPS Diluted | -260.80% | -63.01% | -98.03% | -2,930.10% | 10.39% |
| Normalized Diluted EPS | 82.26% | 6.35% | 246.14% | 108.61% | 15.79% |
| Average Basic Shares Outstanding | -0.75% | -1.70% | -3.67% | -4.31% | -6.79% |
| Average Diluted Shares Outstanding | -25.82% | -0.94% | -26.94% | -4.52% | -5.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |